LANCASTER, Pa., October 11, 2007—Lancaster Laboratories has launched its innovative web portal LabAccessSM which offers pharmaceutical clients a secure on-line window to comprehensive analytical information as their project progresses. With LabAccessSM, pharmaceutical clients may view extensive project information such as analysts’ notebooks, chromatograms, approved test results, Certificates of Analysis, raw data packages and invoices.
“Convenient and timely access to project information as well as multiple points of contact throughout the contract laboratory organization for our clients are critical to project success,” says Dr. Timothy S. Oostdyk, Lancaster Laboratories executive vice president and chief operating officer. “At Lancaster Labs, we’ve built what we believe to be the most comprehensive range of technical capabilities and regulatory expertise in contract analytical services. Ultimately, delivering our product to clients in the most proficient way is paramount. And LabAccessSM takes open communication to a new level.”
LabAccessSM is available 24/7 to all Lancaster Laboratories clients who have a valid e-mail address in the Lancaster Laboratories LIMS system. Clients interested in procuring their secure LabAccessSM account may visit www.labaccess.com.
Lancaster Laboratories is part of Thermo Fisher Scientific Inc. (NYSE: TMO). Thermo Fisher is the world leader in serving science, enabling customers to make the world healthier, cleaner and safer. With an annual revenue rate of more than $9 billion, the company employs 30,000 people and serves more than 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Visit www.thermofisher.com.